India’s First Tele Case Discussion Platform for Doctors. A unique network of Doctors which is dedicated to improving quality of and access to healthcare.
We are pleased to welcome Dr. Gabriel Anzueto to CLIRNET, where he brings his expertise in developmental pediatrics!
Welcome aboard, Dr. Anzueto!
#Pediatrics#MedicalExperts#CLIRNET
𝐑𝐞𝐭𝐢𝐟𝐚𝐧𝐥𝐢𝐦𝐚𝐛-𝐝𝐥𝐰𝐫 𝐟𝐨𝐫 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐒𝐂𝐀𝐂:
• 1st-line: With carboplatin + paclitaxel
• 2nd-line: As monotherapy after platinum failure
• Dosing: 500 mg IV every 4 weeks
✅ Shown to improve survival outcomes
✅ Now FDA-approved in the U.S.
On #WorldNoTobaccoDay, we spotlight a major consequence of tobacco use: oral cancer.
In India, over 30% of cancers are oral—many linked to smokeless tobacco.
Early detection saves lives.
#OralCancerAwareness#PublicHealth
A game-changer in 𝐒𝐓𝐈 𝐜𝐨𝐧𝐭𝐫𝐨𝐥.
NHS England’s August launch of the 4C-MenB vaccine marks the first-ever approved 𝐠𝐨𝐧𝐨𝐫𝐫𝐡𝐞𝐚 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 for public use.
A strong step forward in sexual health and preventive medicine.
#STI#PublicHealth
🚨 FDA Accelerated Approval Alert
A new milestone in NSCLC care — Telisotuzumab vedotin-tllv receives accelerated approval.
A promising advancement in precision oncology.
#oncology#lungcancer#NSCLC#FDC#ADC#TargetedTherapy
𝐏𝐫𝐢𝐦𝐞 𝐞𝐝𝐢𝐭𝐢𝐧𝐠 shows real clinical promise.
It corrected a single-point mutation in chronic granulomatous disease, restoring enzyme function in most neutrophils—without serious side effects.
A major leap for 𝐠𝐞𝐧𝐨𝐦𝐞 𝐞𝐝𝐢𝐭𝐢𝐧𝐠.
#GeneEditing#Innovation
We’re pleased to welcome Dr. Vijendra Chaturvedi (MBBS, DPM, DCH, DNB - Paediatrics) to the CLIRNET network.
At CLIRNET, we aim to foster collaboration, knowledge-sharing, and innovation in healthcare - and we’re excited to have Dr. Chaturvedi as part of this journey.
#CLIRNET
🧪 A new garlic-derived 𝐧𝐚𝐧𝐨𝐯𝐞𝐬𝐢𝐜𝐥𝐞 𝐡𝐲𝐝𝐫𝐨𝐠𝐞𝐥 delivers vancomycin straight into infected cells - targeting 𝘚𝘵𝘢𝘱𝘩𝘺𝘭𝘰𝘤𝘰𝘤𝘤𝘶𝘴 𝘢𝘶𝘳𝘦𝘶𝘴 and showing the infection with a colour change.
#DrugDelivery#Biomedical
#DrugDevelopment#HealthTech
From farm to pharma!
Edible plant-derived exosomes are gaining ground as a safe delivery system for siRNA and miRNA - offering a low-toxicity, stable, and immune-friendly pathway to precision gene therapies.
#RNA#PrecisionMedicine#CancerResearch#DrugDevelopment#Biopharma
We’re excited to welcome Dr. Harsha Sinha (MBBS, MD, DM – AIIMS, New Delhi), Associate Consultant in Critical Care Medicine at Indraprastha Apollo Hospitals, to the CLIRNET family.
#CLIRNET#DoctorNetwork#MedicalLeadership#OnlyForDoctors